Patent holdings for IPC class A61K 31/24

Total number of patents in this class: 519

10-year publication summary

49
42
28
44
48
33
39
23
28
18
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Cardioxyl Pharmaceuticals, Inc.
49
10
Theravance Biopharma R&D IP, LLC
457
8
Bristol-myers Squibb Company
4840
7
The Regents of the University of California
20153
7
Baxter International Inc.
2414
7
Baxter Healthcare S.A.
1837
7
Aeromics, Inc.
29
7
Locl Pharma, Inc.
19
7
The Johns Hopkins University
5730
6
Techfields Pharma Co., Ltd.
30
6
University of Mississippi
156
6
Board of Regents, The University of Texas System
5891
5
Ltd "valenta-intellekt"
157
5
Provident Bank
40
5
Bioxcel Therapeutics, Inc.
82
5
Novartis AG
10707
4
Massachusetts Institute of Technology
10121
4
Nevada Naturals Inc.
20
4
The Scripps Research Institute
1351
4
XenoPort, Inc.
85
4
Other owners 401